Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF and Frankfurt:6BX) (the “Company” or “Relevium”), announces its intention to create a…

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that the company…

Cannabis Companies: Stocks on the TSXV

The growth of the cannabis industry has made it possible for companies to offer investment opportunities…

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), announced today it has executed an…

Leveraging Cannabinoids in Pediatric Medicine

Research into the therapeutic benefits of cannabis is prompting a paradigm shift in many sectors of…

Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSXV:RLV,  OTCQB:RLLVF and Frankfurt:6BX (the…

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to announce that Biocannabix…

Relevium Closes Private Placement Financing

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that it…

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to provide a corporate…

Relevium Acquires Exclusive Licence From California Based Cannakids®

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its…